|
The Future of Medicine Regenerative Medicine and Stem Cell Therapies
September 23, 2009 5:15—8:30 Networking and Program |
|
2009 Flagship Series |
|
Regenerative Medicine is the integration of tissue engineering and cell technologies for the repair or regeneration of the structure and function of tissues damaged by aging or disease. Significant progress has been made in the clinical application of adult stem cells, in particular bone marrow derived stromal cells (BMSCs).
We have assembled an outstanding panel of world class experts in the clinical application of stem cell therapies to explore the road map for advances, commercialization and how the future of medicine will be impacted by developments in Regenerative Medicine and Stem Cell Therapies
|
|
Annemarie Moseley, Ph.D. M.D., is the CEO of REPAIR Technologies Brett Cornwell, Director of Commercialization Services, Office of Technology Commercialization, Texas A&M University System Frank Marini, Ph.D. The University of Texas M. D. Anderson Cancer Center, Department of Stem Cell Transplantation Research Deborah Mansfield, HTC, Development Director, Life Sciences and Associate Director, Gulf Coast RCIC |
|
Additional information Event Contact: Dale Wilkins (dale@amchouston.com) |
|
When: Wednesday, September 23rd 6:00 Program 7:30 Networking 8:30 Closing |
Where: 6550 Bertner St |
Cost: Members and MIT Alumni - $40 paid in advance
|